Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

LUNG Pulmonx Corporation Common Stock
$2.80 -2.10% -0.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy LUNG stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Pulmonx Corporation Common Stock (LUNG)

Loading

Key Stats

Market cap. 121.9M
Enterprise value 128.2M
Trailing PE -2.1015038167624
Forward PE -3.1154683
PEG Ratio 0.05704081788355
Enterprise to EBITDA -3.329
Enterprise to revenue 1.444
Price to book MRQ 3.6433117
Price to sales TTM 1.4030402

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 88.8M
EBITDA -38518000
Diluted EPS TTM -1.01
Total Cash (MRQ) 52.7M
Current ratio (MRQ) 4.053
Operating Cash Flow (TTM) -25578000

LUNG trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent LUNG News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.